Pharmacological bypass of NAD+ salvage pathway protects neurons from chemotherapy-induced degeneration
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological bypass of NAD+ salvage pathway protects neurons from chemotherapy-induced degeneration
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201809392
Publisher
Proceedings of the National Academy of Sciences
Online
2018-09-27
DOI
10.1073/pnas.1809392115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nicotinamide riboside, a form of vitamin B3, protects against excitotoxicity-induced axonal degeneration
- (2017) Pauline Vaur et al. FASEB JOURNAL
- The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD + Cleavage Activity that Promotes Pathological Axonal Degeneration
- (2017) Kow Essuman et al. NEURON
- Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy
- (2017) Nicolas Diguet et al. CIRCULATION
- Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lackingSarm1
- (2016) Nils Henninger et al. BRAIN
- Biosensor reveals multiple sources for mitochondrial NAD+
- (2016) X. A. Cambronne et al. SCIENCE
- NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion
- (2016) Yo Sasaki et al. eLife
- Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
- (2016) Samuel A.J. Trammell et al. Scientific Reports
- NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
- (2015) Carles Cantó et al. Cell Metabolism
- SARM1 activation triggers axon degeneration locally via NAD+ destruction
- (2015) J. Gerdts et al. SCIENCE
- A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
- (2014) M Di Stefano et al. CELL DEATH AND DIFFERENTIATION
- Wallerian degeneration: an emerging axon death pathway linking injury and disease
- (2014) Laura Conforti et al. NATURE REVIEWS NEUROSCIENCE
- Chemotherapy-induced peripheral neurotoxicity: A critical analysis
- (2013) Susanna B. Park et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions
- (2013) J. Gerdts et al. JOURNAL OF NEUROSCIENCE
- TARGETED, LCMS-BASED METABOLOMICS FOR QUANTITATIVE MEASUREMENT OF NAD + METABOLITES
- (2013) Samuel AJ Trammell et al. Computational and Structural Biotechnology Journal
- Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention
- (2012) W. Grisold et al. NEURO-ONCOLOGY
- dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway
- (2012) J. M. Osterloh et al. SCIENCE
- Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells
- (2011) Andrey Nikiforov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons
- (2010) Jonathan Gilley et al. PLOS BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started